aod9604 weight loss fat muscle preservation safety Transformative AOD-9604 Fat Loss Peptide Therapy AOD-9604 Peptide Informed Consent Form
Description
doi:10.3390/nu6051861

Subcutaneous injections exceeding 0.5mL per site reduce absorption efficiency due to depot formation

"Obesity drugs in clinical development." Current Opinion in Investigational Drugs 7.4 (2006): 312

Thats because there is no set formula for what is in these injections

Most protocols begin with 1-2 injections weekly for 4-8 weeks
